Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: The National Cooperative Growth Study experience-Reference-Cited by-同舟云学术

Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: The National Cooperative Growth Study experience

Published:1996-05 Issue:5 Volume:128 Page:S22-S27
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Chernausek Steven D.,Breen Timothy J.,Frank Graeme R.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference13 articles.

1. Long-term growth in small-for-date children;Fitzhardinge;Acta Paediatr Scand,1989

2. Growth responses to human growth hormone in patients with intrauterine growth retardation;Foley;J Pediatr,1974

3. Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism;Grunt;J Clin Endocrinol Metab,1972

4. Sustained effect of human growth hormone therapy on children with intrauterine growth retardation;Lanes;Pediatrics,1976

5. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints;Tanner;Arch Dis Child,1971

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Application of Sequential Epigenetic Analysis for Diagnosis of Silver–Russell Syndrome;Annals of Laboratory Medicine;2021-07-01

2. SILVER–RUSSELL SYNDROME;Cassidy and Allanson's Management of Genetic Syndromes;2020-10-30

3. Growth hormone, growth hormone secretagogues, and insulin-like growth factor-1 in sports: prohibited status, therapeutic use exemptions, and analytical detectability;Current Opinion in Endocrine and Metabolic Research;2019-12

4. Diagnosis and management of Silver–Russell syndrome: first international consensus statement;Nature Reviews Endocrinology;2016-09-02

5. A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study;Clinical Endocrinology;2015-11-25